Suzdak Peter David 4
4 · REXAHN PHARMACEUTICALS, INC. · Filed Aug 16, 2017
Insider Transaction Report
Form 4
Suzdak Peter David
Chief Executive Officer
Transactions
- Award
Common Stock
2017-08-16$1.99/sh+10,000$19,872→ 16,000 total
Footnotes (1)
- [F1]The price of $1.9872 per share represents a weighted average of purchase prices ranging from $1.96 to $2.01 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.